(Q44212152)

30 November 2017

title

Early infection in liver transplant recipients: incidence, severity, risk factors and antibiotic sensitivity of bacterial isolates (English)

1 reference

30 November 2017

1 reference

Isabel Losada

1

1 reference

30 November 2017

Valentín Cuervas-Mons

series ordinal

2

1 reference

30 November 2017

Isabel Millán

series ordinal

3

1 reference

30 November 2017

Diego Dámaso

series ordinal

4

1 reference

30 November 2017

language of work or name

Spanish

0 references

publication date

1 November 2002

1 reference

Infectious Diseases and Clinical Microbiology

30 November 2017

published in

1 reference

30 November 2017

volume

20

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

422-430

1 reference

Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Infections in liver transplantation: risk factors and strategies for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Infections in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Selective bowel decontamination with quinolones and nystatin reduces gram-negative and fungal infections in orthotopic liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Bacterial and fungal infections after liver transplantation: an analysis of 284 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Risk factors for systemic fungal infections in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Risk factors for invasive fungal infections complicating orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Cytomegalovirus Disease as a Risk Factor for Graft Loss and Death After Orthotopic Liver Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Detection of cytomegalovirus infections in specimens other than urine by the shell vial assay and conventional tube cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

The first 100 liver transplantations at the Mayo Clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

The first 100 liver transplants at UCLA.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Fungal infections in solid-organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Cytomegalovirus and death in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Nutrition management of the hepatic transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Bacterial Infection as a Complication of Liver Transplantation: Epidemiology and Risk Factors

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Clinical spectrum of fungal infections after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Fluconazole resistance in Candida glabrata

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Fluconazole resistance in Candida glabrata

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Effectiveness of daily low-dose cotrimoxazole prophylaxis for Pneumocystis carinii pneumonia in liver transplantation--an open clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

An outbreak of vancomycin-resistant Enterococcus faecium in liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972837-1

7 January 2021

10.1016/S0213-005X(02)72837-1

Identifiers

DOI

1 reference

30 November 2017

1 reference